SPY338.13+3.24 0.97%
DIA279.86+2.36 0.85%
IXIC11,297.24+129.73 1.16%

Guardant Health shares are trading higher after the company received Emergency Use Authorization from the FDA for its Guardant-19 next generation sequencing-based Covid-19 test.

Benzinga · 08/24/2020 19:44